Blue Wave Therapeutics at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Blue Wave Therapeutics at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).

OrganizationBIO-Europe 2026 Attendance
bluewavetherapeutics.com
Biotech
Preclinical company developing targeted radionuclide therapies for solid tumors, carried by alginate nanoparticles, with glioblastoma as its lead indication.
Panel
Wed Nov 11
11:00–11:45
Capital with a Mission: Investing Beyond Traditional Venture Models
How mission-driven and foundation investors fund neglected diseases such as glioblastoma and neuroblastoma that venture capital passes over, focusing on Switzerland.
with Cellula Therapeutics, Remora Biotech

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Blue Wave Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction